Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
IKZF1 deletion
i
Other names:
IKZF1, IKAROS Family Zinc Finger 1, Zinc Finger Protein Subfamily 1A 1 (Ikaros), Protein Phosphatase 1 Regulatory Subunit 92, Ikaros Family Zinc Finger Protein 1, Lymphoid Transcription Factor LyF-1, DNA-Binding Protein Ikaros, ZNFN1A1, IKAROS, LYF1, IK1, IKAROS Family Zinc Finger 1 (Ikaros), CLL-Associated Antigen KW-6, Hs.54452, PPP1R92, PRO0758, CVID13, LyF-1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
10320
Related biomarkers:
Expression
Mutation
CNA
‹
IKZF1 mutation (3)
TP53 mutation + IKZF1 mutation (1)
IKZF1 mutation (3)
TP53 mutation + IKZF1 mutation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
IKZF1 deletion
Acute Myelogenous Leukemia
IKZF1 deletion
Acute Myelogenous Leukemia
ponatinib
Resistant: C3 – Early Trials
ponatinib
Resistant
:
C3
ponatinib
Resistant: C3 – Early Trials
ponatinib
Resistant
:
C3
IKZF1 deletion
Acute Lymphocytic Leukemia
IKZF1 deletion
Acute Lymphocytic Leukemia
dasatinib + blinatumomab
Resistant: C3 – Early Trials
dasatinib + blinatumomab
Resistant
:
C3
dasatinib + blinatumomab
Resistant: C3 – Early Trials
dasatinib + blinatumomab
Resistant
:
C3
IKZF1 deletion
Acute Lymphocytic Leukemia
IKZF1 deletion
Acute Lymphocytic Leukemia
dasatinib
Sensitive: C3 – Early Trials
dasatinib
Sensitive
:
C3
dasatinib
Sensitive: C3 – Early Trials
dasatinib
Sensitive
:
C3
IKZF1 deletion
B Acute Lymphoblastic Leukemia
IKZF1 deletion
B Acute Lymphoblastic Leukemia
CD19-targeted CAR-T immunotherapy
Resistant: C3 – Early Trials
CD19-targeted CAR-T immunotherapy
Resistant
:
C3
CD19-targeted CAR-T immunotherapy
Resistant: C3 – Early Trials
CD19-targeted CAR-T immunotherapy
Resistant
:
C3
IKZF1 deletion
Acute Lymphocytic Leukemia
IKZF1 deletion
Acute Lymphocytic Leukemia
cytarabine
Resistant: D – Preclinical
cytarabine
Resistant
:
D
cytarabine
Resistant: D – Preclinical
cytarabine
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login